Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
An update from Indivior ( (INDV) ) is now available.
Indivior PLC has announced the granting of performance share units (PSUs) and restricted share units (RSUs) to its CEO, Joe Ciaffoni, as part of his compensation package. These awards, which involve a significant number of shares, are structured to vest over several years, contingent on continued employment and the achievement of specific performance conditions related to the company’s share price. This move underscores the company’s commitment to aligning executive incentives with shareholder interests and reflects a strategic focus on long-term growth and stability.
More about Indivior
Indivior PLC operates in the pharmaceutical industry, focusing on the development and commercialization of medications for the treatment of addiction and its co-occurring disorders. The company is known for its innovative therapies aimed at addressing the global opioid crisis and other addiction-related issues.
For a thorough assessment of INDV stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue